New patent expiration for Glaxosmithkline Cons drug EXCEDRIN (MIGRAINE)

Annual Drug Patent Expirations for EXCEDRIN+%28MIGRAINE%29 Excedrin (migraine) is a drug marketed by Glaxosmithkline Cons and is included in one NDA. It is available from five suppliers. There is one… The post New patent expiration for Glaxosmithkline Cons drug EXCEDRIN (MIGRAINE) appeared first on DrugPatentWatch - Make Better Decisions.

Comments are closed.

Do NOT follow this link or you will be banned from the site!
%d bloggers like this: